These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy. Takahashi Y; Nishikawa M; Takakura Y Adv Drug Deliv Rev; 2009 Jul; 61(9):760-6. PubMed ID: 19386274 [TBL] [Abstract][Full Text] [Related]
6. Use of RNA interference libraries to investigate oncogenic signalling in mammalian cells. Downward J Oncogene; 2004 Nov; 23(51):8376-83. PubMed ID: 15517019 [TBL] [Abstract][Full Text] [Related]
7. Antisense apolipoprotein B therapy: where do we stand? Akdim F; Stroes ES; Kastelein JJ Curr Opin Lipidol; 2007 Aug; 18(4):397-400. PubMed ID: 17620855 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of RNA interference for neurological disorders. Sah DW Life Sci; 2006 Oct; 79(19):1773-80. PubMed ID: 16815477 [TBL] [Abstract][Full Text] [Related]
9. RNA interference technologies and their use in cancer research. Gaither A; Iourgenko V Curr Opin Oncol; 2007 Jan; 19(1):50-4. PubMed ID: 17133112 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic gene targeting approaches for the treatment of dyslipidemias and atherosclerosis. Mäkinen PI; Ylä-Herttuala S Curr Opin Lipidol; 2013 Apr; 24(2):116-22. PubMed ID: 23314926 [TBL] [Abstract][Full Text] [Related]
12. RNA interference: emerging diagnostics and therapeutics tool. Shrey K; Suchit A; Nishant M; Vibha R Biochem Biophys Res Commun; 2009 Aug; 386(2):273-7. PubMed ID: 19523438 [TBL] [Abstract][Full Text] [Related]
13. SiLEncing SLE: the power and promise of small noncoding RNAs. Rigby RJ; Vinuesa CG Curr Opin Rheumatol; 2008 Sep; 20(5):526-31. PubMed ID: 18698172 [TBL] [Abstract][Full Text] [Related]
14. Management of chronic hepatitis B virus infection: a promising approach using small interfering RNA (siRNA). Dwivedi M; Misra SP; Misra V; Waikhom RK; Bhatnagar M Natl Med J India; 2008; 21(3):123-7. PubMed ID: 19004143 [TBL] [Abstract][Full Text] [Related]
15. In vivo target validation using gene invalidation, RNA interference and protein functional knockout models: it is the time to combine. Vidalin O; Muslmani M; Estienne C; Echchakir H; Abina AM Curr Opin Pharmacol; 2009 Oct; 9(5):669-76. PubMed ID: 19646923 [TBL] [Abstract][Full Text] [Related]
16. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice. Xu W; Wang LW; Shi JZ; Gong ZJ Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172 [TBL] [Abstract][Full Text] [Related]
17. [RNA interference and molecular pathology of selected diseases]. Lochmanová J; Bartos M Cas Lek Cesk; 2008; 147(12):607-15. PubMed ID: 19235485 [TBL] [Abstract][Full Text] [Related]
18. [Genetics of dyslipidemia--yesterday, today, and tomorrow]. Hubácek JA; Vrablík M Vnitr Lek; 2007 Apr; 53(4):371-6. PubMed ID: 17578168 [TBL] [Abstract][Full Text] [Related]
19. Asymmetric RNA duplexes mediate RNA interference in mammalian cells. Sun X; Rogoff HA; Li CJ Nat Biotechnol; 2008 Dec; 26(12):1379-82. PubMed ID: 19029911 [TBL] [Abstract][Full Text] [Related]
20. Small silencing RNAs: state-of-the-art. Grimm D Adv Drug Deliv Rev; 2009 Jul; 61(9):672-703. PubMed ID: 19427885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]